Sumatriptan, a selective serotonin receptor (5-HT1B/1D) agonist, rapidly alleviates cluster headache symptoms by causing vasoconstriction and inhibiting neurogenic inflammation in cerebral blood vessels. When administered via subcutaneous injection, it provides fast-acting relief by binding to serotonin receptors and disrupting pain signal transmission, with onset of action typically within 10-15 minutes.